BioWorld MedTech

Jan. 4, 2012

TransEnterix develops laparoscopic vessel sealer, stapler for Spider

Surgeons should be getting a couple new tools to be excited about in the not-too-distant future a flexible vessel sealer and a flexible stapler from TransEnterix (Research Triangle Park, North Carolina). Read More

Med-tech took a beating in 2011; but will 2012 be any better?

Report from Europe: SeptRx reports completing initial enrollment for InterSEPT trial

ASH 2011: Imaging modailities' role in hemotology greatly reduced

Financings roundup: Uptake raises $35 million; eyes InterVapor approval

Deals roundup: Accelrys buys VelQuest for $35 million in cash

Agreements/contracts: Radisphere to partner with Northeast Regional Medical

Patent watch: DR Systems obtains imaging display patent from USPTO

Product Briefs

People in the News

Welch Allyn president/CEO Shimer to retire at end of year

HIT roundup: AAPHC using eClinicalWorks EHR across 14 locations

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...